Juno Therapeutics, Inc. 4
4 · Juno Therapeutics, Inc. · Filed Mar 2, 2016
Insider Transaction Report
Form 4
Frohlich Mark W
See Remarks
Transactions
- Sale
Common Stock
2016-02-29$35.25/sh−19,700$694,392→ 919,883 total - Sale
Common Stock
2016-02-29$36.50/sh−300$10,950→ 919,583 total
Footnotes (4)
- [F1]This transaction was executed in multiple trades at prices ranging from $34.79 to $35.76. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]This transaction was executed in multiple trades at prices ranging from $36.40 to 36.55. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2014 and amended on March 20, 2015.
- [F4]Includes 2,083 shares acquired under the issuer's employee stock purchase plan on November 16, 2015.